TIAA CREF INVESTMENT MANAGEMENT LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2019$7,514,000
+46.4%
93,861
-1.4%
0.01%
+25.0%
Q4 2018$5,134,000
-66.4%
95,239
-51.4%
0.00%
-20.0%
Q3 2018$15,294,000
+127.6%
195,922
+85.1%
0.01%0.0%
Q2 2018$6,720,000
-36.3%
105,853
-8.1%
0.01%
-28.6%
Q1 2018$10,557,000
+21.1%
115,122
-0.4%
0.01%
+16.7%
Q4 2017$8,720,000
+6.7%
115,631
-1.4%
0.01%0.0%
Q3 2017$8,172,000
+32.3%
117,296
-3.8%
0.01%
+50.0%
Q2 2017$6,179,000
+143.7%
121,941
+92.3%
0.00%
+100.0%
Q1 2017$2,536,000
+56.8%
63,428
+10.1%
0.00%
+100.0%
Q4 2016$1,617,000
-13.9%
57,633
-8.9%
0.00%0.0%
Q3 2016$1,878,000
+44.8%
63,229
-1.3%
0.00%0.0%
Q2 2016$1,297,000
+126.7%
64,067
+102.1%
0.00%
Q1 2016$572,000
-31.5%
31,7060.0%0.00%
-100.0%
Q4 2015$835,000
+23.3%
31,7060.0%0.00%0.0%
Q3 2015$677,000
-50.9%
31,706
-39.1%
0.00%0.0%
Q2 2015$1,379,00052,0660.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2016
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders